We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$97.6B
AUM Growth
+$7.83B
Cap. Flow
-$1.4B
Cap. Flow %
-1.44%
Top 10 Hldgs %
8.44%
Holding
2,812
New
276
Increased
1,047
Reduced
1,341
Closed
81

Sector Composition

Rank Sector Weight
1 Technology 17.69%
2 Industrials 14.24%
3 Financials 12.51%
4 Consumer Discretionary 11.88%
5 Healthcare 10.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVFM
2676
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$27K ﹤0.01%
1,032
+178
+21% +$8.09K
ABEO icon
2677
Abeona Therapeutics
ABEO
$413M
$26K ﹤0.01%
563
-18
-3% -$992
BCIC
2678
BCP Investment Corp
BCIC
$92.9M
$26K ﹤0.01%
1,221
-34
-3% -$686
CATX icon
2679
Perspective Therapeutics
CATX
$342M
$25K ﹤0.01%
2,294
+833
+57% +$12.6K
JAGX icon
2680
Jaguar Health
JAGX
$4.67M
0
PTN
2681
Palatin Technologies
PTN
$13.8M
$24K ﹤0.01%
28
-1
-3% -$1.05K
OSG
2682
DELISTED
Overseas Shipholding Group Inc.
OSG
$24K ﹤0.01%
11,783
-366
-3% -$807
ATOS icon
2683
Atossa Therapeutics
ATOS
$23.5M
$23K ﹤0.01%
+736
New +$26.9K
AVGR
2684
DELISTED
Avinger, Inc. Common Stock
AVGR
$23K ﹤0.01%
50
+4
+9% +$1.92K
AGRX
2685
DELISTED
Agile Therapeutics
AGRX
$23K ﹤0.01%
5
-1
-17% -$5.41K
PEI
2686
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$21K ﹤0.01%
741
-76
-9% -$2.26K
DMK
2687
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$20K ﹤0.01%
302
+87
+40% +$6.78K
ZSAN
2688
DELISTED
Zosano Pharma Corporation
ZSAN
$20K ﹤0.01%
469
+91
+24% +$3.81K
UAMY icon
2689
United States Antimony
UAMY
$1.02B
$19K ﹤0.01%
15,694
+5,416
+53% +$6.04K
BIOL
2690
DELISTED
Biolase, Inc.
BIOL
$19K ﹤0.01%
9
+3
+50% +$7.37K
ASRT
2691
DELISTED
Assertio
ASRT
$18K ﹤0.01%
430
+164
+62% +$8.14K
FTK icon
2692
Flotek Industries
FTK
$1.28B
$18K ﹤0.01%
1,781
-76
-4% -$945
INUV icon
2693
Inuvo
INUV
$17M
$18K ﹤0.01%
1,752
+395
+29% +$4.78K
IMNN icon
2694
Imunon
IMNN
$6.77M
$17K ﹤0.01%
+62
New +$20.8K
VGZ icon
2695
Vista Gold
VGZ
$308M
$17K ﹤0.01%
15,956
-386
-2% -$392
XTIA icon
2696
XTI Aerospace
XTIA
$58.9M
0
RNTX
2697
Rein Therapeutics
RNTX
$69.9M
$16K ﹤0.01%
+543
New +$18.6K
OGEN icon
2698
Oragenics
OGEN
$2.48M
$15K ﹤0.01%
9
+1
+13% +$1.82K
RMTI icon
2699
Rockwell Medical
RMTI
$28.2M
$15K ﹤0.01%
120
+5
+4% +$739
GRDX
2700
GridAI Technologies Corp
GRDX
$19.2M
0

Similar funds

Victory Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Victory Capital Management held 2,812 positions worth $97.6B, up 8.7% from $89.8B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Victory Capital Management's Q1 2021 filing shows 276 new, 1,047 increased, 1,341 reduced and 81 closed positions. Its largest new stake was Vanguard Total World Stock ETF: 4,912,065 shares worth $478M. The largest sale was Coherent Inc, an estimated $371M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q1 2021 buy was Vanguard Total World Stock ETF: 4,912,065 shares worth $478M.
  • Victory Capital Management added most to International Flavors & Fragrances in Q1 2021, an estimated $257M increase.
  • Victory Capital Management's biggest Q1 2021 reduction was Coherent Inc, cutting an estimated $371M.
  • Victory Capital Management fully exited iShares MSCI Emerging Markets ETF in Q1 2021, selling an estimated $166M.
  • Victory Capital Management's ten largest holdings make up 8.4% of its $97.6B portfolio in Q1 2021.
  • Victory Capital Management opened 276 new positions and closed 81 in Q1 2021.
  • Victory Capital Management's portfolio value rose 8.7% quarter-over-quarter to $97.6B.

Based on Victory Capital Management's 13F filing for Q1 2021, filed 4 May 2021.